To confirm the ability of Cyr61 to promote CRC migration and invasion via integrin αVβ5, we employed the integrin αVβ5 inhibitor EMD 121974 (EMD) and integrin β5‐specific shRNA (shβ5). Here, CCN1 is linked to colorectal carcinoma.